Venlafaxine in the treatment of depression in schizophrenia
Objective: Depression in schizophrenia is associated with a poor outcome, an increased risk of relapse and a high rate of suicide therefore it must be treated carefully. Venlafaxine is a dual-action serotonin and noradrenergic reuptake inhibitor and is effective in treating depressive patients. M...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Mesut Çetin
2021-03-01
|
| Colección: | Psychiatry and Clinical Psychopharmacology |
| Materias: | |
| Acceso en línea: | https://psychiatry-psychopharmacology.com/index.php/pub/article/view/426 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|